Figure 7.
Characterization of serum samples obtained from mice vaccinated with MVA-p30 constructs. BALB/c mice were primed and boosted (days 21 and 35) with either MVA-PrMVA-13.5L-p30, MVA-S E/L-C13L-p30, MVA-PrS5E-p30, or MVA-GFP. Purified p30 protein (baculovirus-expressed) were used as coating antigen for ELISA assays. Detection of specific anti-p30 antibodies at days 21, 28, and 42 p.i. for all animal groups are shown (n = 4 mice per group). Statistically significant differences between antibody titers are shown (P < 0.05, one-way ANOVA with Tukey’s multiple comparison test) *P < 0.05; **P < 0.005; ***P < 0.0005.